India Glycols Outlines Cost Apportionment for Bio Pharma and Spirits Demergers
India Glycols Ltd 路 Others (Uncategorized) 路 06 Oct 2026, 11:32 pm
India Glycols Outlines Cost Apportionment for Bio Pharma and Spirits Demergers Pursuant to the NCLT-sanctioned Scheme of Arrangement effective 1st Sep'26, India Glycols Limited completed the demerger of its Bio Pharma and Spirits & Biofuel undertakings into Ennature Bio Pharma Limited and IGL Spirits Limited, respectively. For determining post-demerger acquisition costs under tax regulations, original acquisition costs are apportioned as 31.77% to India Glycols Limited, 20.61% to Ennature Bio Pharma Limited, and 47.62% to IGL Spirits Limited. Share entitlement ratios were 1:3 for Ennature Bio Pharma and 1:1 for IGL Spirits against existing holdings as of 2nd Sep'26.
Original exchange filing (PDF)
More announcements from India Glycols Ltd
- Please find attached. 路 18 Nov 2026
- Please find attached. 路 17 Nov 2026
- Please find atached. 路 13 Nov 2026
- India Glycols Limited has informed the Exchange about General Updates 路 13 Nov 2026
- Please find attached. 路 13 Nov 2026
- India Glycols Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Please refer to attachment. 路 13 Nov 2026
- Please find attached 路 18 Nov 2026
